Meribank Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	958	1,438	2,463	2,392	-	-
Market Cap Growth	-38.49%	-41.61%	2.99%	-	-	-
Enterprise Value	1,867	2,450	2,542	2,260	-	-
Last Close Price	9.98	16.35	27.99	38.09	-	-
PS Ratio	2.03	3.05	6.72	10.21	-	-
PB Ratio	0.76	1.14	2.02	3.56	-	-
P/TBV Ratio	2.28	3.42	7.26	3.81	-	-
P/FCF Ratio	11.19	16.80	-	-	-	-
P/OCF Ratio	10.71	16.08	-	-	-	-
EV/Sales Ratio	3.96	5.19	6.94	9.64	-	-
EV/EBITDA Ratio	18.95	339.46	-	-	-	-
EV/FCF Ratio	21.81	28.62	-	-	-	-
Debt / Equity Ratio	0.90	0.90	0.77	0.05	0.10	0.09
Debt / EBITDA Ratio	11.04	11.04	-	-	-	-
Debt / FCF Ratio	13.17	13.17	-	-	-	-
Net Debt / Equity Ratio	0.71	0.71	0.64	-0.54	-0.34	-0.40
Net Debt / EBITDA Ratio	124.46	124.46	-15.32	3.30	1.65	2.71
Net Debt / FCF Ratio	10.49	10.49	-2.71	10.29	3.56	7.72
Asset Turnover	0.17	0.17	0.20	0.25	0.20	0.19
Inventory Turnover	30.52	30.52	19.01	12.44	14.17	22.33
Quick Ratio	1.71	1.71	1.43	4.21	3.30	4.54
Current Ratio	1.90	1.90	1.69	4.49	3.60	4.79
Return on Equity (ROE)	-6.63%	-6.63%	-10.27%	-22.62%	-19.46%	-20.48%
Return on Assets (ROA)	-1.19%	-1.19%	-2.94%	-8.01%	-7.65%	-7.25%
Return on Capital Employed (ROCE)	-2.00%	-2.00%	-3.60%	-13.10%	-14.90%	-11.40%
Earnings Yield	-8.51%	-5.66%	-3.84%	-5.24%	-	-
FCF Yield	8.94%	5.95%	-11.64%	-1.48%	-	-
Buyback Yield / Dilution	-14.85%	-14.85%	-26.54%	-0.11%	-4.07%	-14.52%